Daniel I. C. Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Daniel I. C. Wang has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
Liangzhi Xie
Merck and Co., Inc., West Point, Pennsylvania, USA
5 shared publicationsMiranda G. S. Yap
Department of Molecular Engineering of Biological and Chemical Systems, Singapore–MIT (Massachusetts Institute of Technology) Alliance, National University of Singapore, Singapore 117576
4 shared publicationsStephen R. Fox
Biotechnology Process Engineering Center (BPEC) and Department of Chemical Engineering, Massachusetts Institute of Technology (MIT), Cambridge, MA 02139, USA
3 shared publicationsXuejun Gu
Biotechnology Process Engineering Center, Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139; telephone: (617)-253-2126; fax: (617)-253-2400
3 shared publicationsBryan J. Harmon
Biotechnology Process Engineering Center, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139; telephone: 617-253-0805; fax: 617-253-2400
2 shared publicationsHong Kiat Tan
Department of Molecular Engineering of Biological and Chemical Systems, Singapore-MIT (Massachusetts Institute of Technology) Alliance, National University of Singapore, Singapore 117576
2 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 5 May 2017
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 3 (5) , e1601984-1601984
Harnessing the hygroscopic and biofluorescent behaviors of genetically tractable microbial cells to design biohybrid wearables
We harnessed the hygroscopic and biofluorescent behaviors of microbial cells to design sweat-responsive biohybrid wearables.
- 5 May 2017
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 3 (5) , e1601984-1601984
Top Cited PapersOpen AccessHarnessing the hygroscopic and biofluorescent behaviors of genetically tractable microbial cells to design biohybrid wearables
We harnessed the hygroscopic and biofluorescent behaviors of microbial cells to design sweat-responsive biohybrid wearables.
- 7 November 2011
- Published by Wiley in Biotechnology Progress
- Vol. 28 (2) , 591-594
High‐throughput analysis of intraclonal variability of glycoprotein sialylation
Development of recombinant Chinese Hamster Ovary (CHO) cells producing therapeutic proteins requires analyzing the quality, such as sialic acid content, of proteins produced by many cell clones. In order to perform these analyses, high‐throughput methods are required. Conventional methods for quantifying sialic acid, however, require protein purification, which is time consuming and cannot be used for high‐throughput analysis. Here we used a high‐throughput method (HTM) that we recently developed to analyze the intraclonal variability of 24 CHO cell subclones. The sialic acid content varied significantly from 1 to 70 mg sialic acid/g protein, and the concentration of total proteins secreted by the cells varied from 41 to 214 mg/L. In addition, the sialic acid content was negatively correlated with total protein concentration. This trend agrees with previous theoretical and experimental studies. Overall, the HTM can finish these analyses in 15 minutes, while conventional methods used in previous studies will require at least 24 days. Thus, the HTM can significantly accelerate the analyses of clonal and intraclonal variability in cell line development © 2011 American Institute of Chemical Engineers Biotechnol. Prog., 2012
- 7 November 2011
- Published by Wiley in Biotechnology Progress
- Vol. 28 (2) , 591-594
High‐throughput analysis of intraclonal variability of glycoprotein sialylation
Development of recombinant Chinese Hamster Ovary (CHO) cells producing therapeutic proteins requires analyzing the quality, such as sialic acid content, of proteins produced by many cell clones. In order to perform these analyses, high‐throughput methods are required. Conventional methods for quantifying sialic acid, however, require protein purification, which is time consuming and cannot be used for high‐throughput analysis. Here we used a high‐throughput method (HTM) that we recently developed to analyze the intraclonal variability of 24 CHO cell subclones. The sialic acid content varied significantly from 1 to 70 mg sialic acid/g protein, and the concentration of total proteins secreted by the cells varied from 41 to 214 mg/L. In addition, the sialic acid content was negatively correlated with total protein concentration. This trend agrees with previous theoretical and experimental studies. Overall, the HTM can finish these analyses in 15 minutes, while conventional methods used in previous studies will require at least 24 days. Thus, the HTM can significantly accelerate the analyses of clonal and intraclonal variability in cell line development © 2011 American Institute of Chemical Engineers Biotechnol. Prog., 2012
- 31 October 2008
- Published by Elsevier in Journal of Biotechnology
- Vol. 136, S114
Biotechnology of mammalian cells
- 31 October 2008
- Published by Elsevier in Journal of Biotechnology
- Vol. 136, S114
Biotechnology of mammalian cells
- 1 April 2008
- Published by Wiley in Biotechnology and Applied Biochemistry
- Vol. 49 (4) , 247-257
Overexpression of cold‐inducible RNA‐binding protein increases interferon‐γ production in Chinese‐hamster ovary cells
Culturing recombinant CHO (Chinese‐hamster ovary) cells at low temperatures (30–33 °C) increases specific recombinant protein productivity by 2–5‐fold. However, even though the specific productivity is increased, cell growth is decreased in low‐temperature culture such that the final recombinant protein titre remains unchanged or is even diminished, owing to the lower cell density. Exposing mammalian cells to low temperatures results in a change in the expression of many ‘cold‐stress’ genes. CIRP (cold‐inducible RNA‐binding protein) is a cold‐stress protein that is highly expressed at 32 °C, but not at 37 °C. In the present study we demonstrated that overexpression of CIRP at 37 °C can increase the recombinant‐protein titre in CHO cells. Stable overexpression of CIRP at 37 °C improved the final titre of CHO IFN‐γ, a recombinant CHO cell line producing human IFN‐γ (interferon‐γ), by 25% in adherent culture and up to 40% in suspension culture. Real‐time PCR analysis showed that the increase in the recombinant IFN‐γ titre could be attributed to increased recombinant IFN‐γ mRNA levels, while growth data showed that CIRP overexpression did not result in growth arrest in CHO IFN‐γ cells. Glycan analysis showed that the increase in IFN‐γ titre as a result of CIRP overexpression did not affect the site occupancy, glycan structures or sialic acid content of IFN‐γ. Using this strategy, the final IFN‐γ titre was increased by 40% compared with current temperature‐based strategies. Furthermore, there is no decrease in cell growth or recombinant‐protein glycosylation quality, as previously observed in low‐temperature culture.
- 1 April 2008
- Published by Wiley in Biotechnology and Applied Biochemistry
- Vol. 49 (4) , 247-257
Overexpression of cold‐inducible RNA‐binding protein increases interferon‐γ production in Chinese‐hamster ovary cells
Culturing recombinant CHO (Chinese‐hamster ovary) cells at low temperatures (30–33 °C) increases specific recombinant protein productivity by 2–5‐fold. However, even though the specific productivity is increased, cell growth is decreased in low‐temperature culture such that the final recombinant protein titre remains unchanged or is even diminished, owing to the lower cell density. Exposing mammalian cells to low temperatures results in a change in the expression of many ‘cold‐stress’ genes. CIRP (cold‐inducible RNA‐binding protein) is a cold‐stress protein that is highly expressed at 32 °C, but not at 37 °C. In the present study we demonstrated that overexpression of CIRP at 37 °C can increase the recombinant‐protein titre in CHO cells. Stable overexpression of CIRP at 37 °C improved the final titre of CHO IFN‐γ, a recombinant CHO cell line producing human IFN‐γ (interferon‐γ), by 25% in adherent culture and up to 40% in suspension culture. Real‐time PCR analysis showed that the increase in the recombinant IFN‐γ titre could be attributed to increased recombinant IFN‐γ mRNA levels, while growth data showed that CIRP overexpression did not result in growth arrest in CHO IFN‐γ cells. Glycan analysis showed that the increase in IFN‐γ titre as a result of CIRP overexpression did not affect the site occupancy, glycan structures or sialic acid content of IFN‐γ. Using this strategy, the final IFN‐γ titre was increased by 40% compared with current temperature‐based strategies. Furthermore, there is no decrease in cell growth or recombinant‐protein glycosylation quality, as previously observed in low‐temperature culture.
- 3 May 2006
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 95 (1) , 106-119
RNA interference of sialidase improves glycoprotein sialic acid content consistency
An important challenge facing therapeutic protein production in mammalian cell culture is the cleavage of terminal sialic acids on recombinant protein glycans by the glycosidase enzymes released by lysed cells into the supernatant. This undesired phenomenon results in a protein product which is rapidly cleared from the plasma by asialoglycoprotein receptors in the liver. In this study, RNA interference was utilized as a genetic approach to silence the activity of sialidase, a glycosidase responsible for cleaving terminal sialic acids on IFN‐γ produced by Chinese Hamster Ovary (CHO) cells. We first identified a 21‐nt double stranded siRNA that reduced endogenous sialidase mRNA and protein activity levels. Potency of each siRNA sequences was compared using real time RT‐PCR and a sialidase activity assay. We next integrated the siRNA sequence into CHO cells, allowing production and selection of stable cell lines. We isolated stable clones with sialidase activity reduced by over 60% as compared to the control cell line. Micellar electrokinetic chromatography (MEKC), thiobarbituric acid assay (TAA), and high performance anion exchange chromatography (HPAEC) coupled to amperometric detection were performed to analyze glycan site occupancy, sialic acid content, and distribution of asialo‐/sialylated‐glycan structures, respectively. Two of the stable clones successfully retained the full sialic acid content of the recombinant IFN‐γ, even upon cells' death. This was comparable to the case where a chemically synthesized sialidase inhibitor was used. These results demonstrated that RNA interference of sialidase can prevent the desialylation problem in glycoprotein production, resulting improved protein quality during the entire cell culture process.
- 3 May 2006
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 95 (1) , 106-119
RNA interference of sialidase improves glycoprotein sialic acid content consistency
An important challenge facing therapeutic protein production in mammalian cell culture is the cleavage of terminal sialic acids on recombinant protein glycans by the glycosidase enzymes released by lysed cells into the supernatant. This undesired phenomenon results in a protein product which is rapidly cleared from the plasma by asialoglycoprotein receptors in the liver. In this study, RNA interference was utilized as a genetic approach to silence the activity of sialidase, a glycosidase responsible for cleaving terminal sialic acids on IFN‐γ produced by Chinese Hamster Ovary (CHO) cells. We first identified a 21‐nt double stranded siRNA that reduced endogenous sialidase mRNA and protein activity levels. Potency of each siRNA sequences was compared using real time RT‐PCR and a sialidase activity assay. We next integrated the siRNA sequence into CHO cells, allowing production and selection of stable cell lines. We isolated stable clones with sialidase activity reduced by over 60% as compared to the control cell line. Micellar electrokinetic chromatography (MEKC), thiobarbituric acid assay (TAA), and high performance anion exchange chromatography (HPAEC) coupled to amperometric detection were performed to analyze glycan site occupancy, sialic acid content, and distribution of asialo‐/sialylated‐glycan structures, respectively. Two of the stable clones successfully retained the full sialic acid content of the recombinant IFN‐γ, even upon cells' death. This was comparable to the case where a chemically synthesized sialidase inhibitor was used. These results demonstrated that RNA interference of sialidase can prevent the desialylation problem in glycoprotein production, resulting improved protein quality during the entire cell culture process.
- 23 January 2006
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 93 (5) , 1005-1016
Enhancing recombinant glycoprotein sialylation through CMP‐sialic acid transporter over expression in Chinese hamster ovary cells
Glycosylation engineering strategies that are currently used to improve quality of recombinant glycoproteins involve the manipulation of glycosyltransferase and/or glycosidase expression. We explored the possibility that over expressing nucleotide sugar transporters, particularly the CMP‐sialic acid transporter (CMP‐SAT) would improve the sialylation process in Chinese hamster ovary cells (CHO). Our hypothesis was that increasing CMP‐SAT in the cells through recombinant means would increase the transport of CMP‐sialic acid into the Golgi, resulting in an increased CMP‐sialic acid intra‐lumenal pool and increased sialylation of the proteins produced. We report the construction of the CMP‐SAT expression vector (pcDNA‐SAT) using hamster CMP‐SAT (GenBank accession number Y12074) and demonstrated its functionality using Lec2 CHO mutant cells. Transfection of pcDNA‐SAT into CHO IFN‐γ, a CHO cell line producing recombinant human interferon‐gamma (IFN‐γ) resulted in single clones that had 2–20 fold increase in total CMP‐SAT expression at the transcript level and 1.8–2.8 fold increase in CMP‐SAT at the protein level when compared to untransfected parent CHO IFN‐γ. This resulted in 4%–16% increase in site sialylation of IFN‐γ. There was also a higher proportion of the more sialylated IFN‐γ glycans produced by the clones. We have thus established a novel strategy for sialylation improvement in recombinant protein production that can be considered singly or along with existing glycosylation improvement strategies, including glycosyltransferase over expression and nucleotide sugar feeding. These multiprong approaches can possibly bring us closer toward the goal of maximum and consistent sialylation in glycoprotein production using mammalian cells.
- 23 January 2006
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 93 (5) , 1005-1016
Enhancing recombinant glycoprotein sialylation through CMP‐sialic acid transporter over expression in Chinese hamster ovary cells
Glycosylation engineering strategies that are currently used to improve quality of recombinant glycoproteins involve the manipulation of glycosyltransferase and/or glycosidase expression. We explored the possibility that over expressing nucleotide sugar transporters, particularly the CMP‐sialic acid transporter (CMP‐SAT) would improve the sialylation process in Chinese hamster ovary cells (CHO). Our hypothesis was that increasing CMP‐SAT in the cells through recombinant means would increase the transport of CMP‐sialic acid into the Golgi, resulting in an increased CMP‐sialic acid intra‐lumenal pool and increased sialylation of the proteins produced. We report the construction of the CMP‐SAT expression vector (pcDNA‐SAT) using hamster CMP‐SAT (GenBank accession number Y12074) and demonstrated its functionality using Lec2 CHO mutant cells. Transfection of pcDNA‐SAT into CHO IFN‐γ, a CHO cell line producing recombinant human interferon‐gamma (IFN‐γ) resulted in single clones that had 2–20 fold increase in total CMP‐SAT expression at the transcript level and 1.8–2.8 fold increase in CMP‐SAT at the protein level when compared to untransfected parent CHO IFN‐γ. This resulted in 4%–16% increase in site sialylation of IFN‐γ. There was also a higher proportion of the more sialylated IFN‐γ glycans produced by the clones. We have thus established a novel strategy for sialylation improvement in recombinant protein production that can be considered singly or along with existing glycosylation improvement strategies, including glycosyltransferase over expression and nucleotide sugar feeding. These multiprong approaches can possibly bring us closer toward the goal of maximum and consistent sialylation in glycoprotein production using mammalian cells.
- 1 June 2005
- Published by Taylor & Francis in Chemical Engineering Communications
- Vol. 192 (6) , 709-724
EXTRACTIVE FERMENTATION OF PHENYLALANINE USING UNCHARGED POLYMERIC BEADS
Extractive fermentation was employed for the production of phenylalanine using an agitated and aerated fermenter. Uncharged polystyrene beads (Amberlite XAD-16) were packed in an external column and used to extract the phenylalanine in an intermittent fashion during the fermentation. Even though no cell separator was used and the fermentation broth was fed directly to the column, the overall system performed well without any clogging of the column. It was found that 43% of the phenylalanine could be extracted during the fermentation, and it was thus proved that extractive fermentation is an effective way to prevent the crystallization of phenylalanine. In addition, fermentation performance as also improved due to the relief of self-inhibition by phenylalanine. When 1.2 L of the beads was used and sufficient hydrophobic nutrients were present, the concentration and productivity increased 18% and 55% greater than in the control fermentation, respectively. These results show that extractive fermentation is a very attractive method to enhance production as well as to avoid crystallization. Numerical simulation modeling was also performed in this study for extractive fermentation. The results from the modeling corroborated the experimental data, thus confirming the reliability of the model.
- 1 June 2005
- Published by Taylor & Francis in Chemical Engineering Communications
- Vol. 192 (6) , 709-724
EXTRACTIVE FERMENTATION OF PHENYLALANINE USING UNCHARGED POLYMERIC BEADS
Extractive fermentation was employed for the production of phenylalanine using an agitated and aerated fermenter. Uncharged polystyrene beads (Amberlite XAD-16) were packed in an external column and used to extract the phenylalanine in an intermittent fashion during the fermentation. Even though no cell separator was used and the fermentation broth was fed directly to the column, the overall system performed well without any clogging of the column. It was found that 43% of the phenylalanine could be extracted during the fermentation, and it was thus proved that extractive fermentation is an effective way to prevent the crystallization of phenylalanine. In addition, fermentation performance as also improved due to the relief of self-inhibition by phenylalanine. When 1.2 L of the beads was used and sufficient hydrophobic nutrients were present, the concentration and productivity increased 18% and 55% greater than in the control fermentation, respectively. These results show that extractive fermentation is a very attractive method to enhance production as well as to avoid crystallization. Numerical simulation modeling was also performed in this study for extractive fermentation. The results from the modeling corroborated the experimental data, thus confirming the reliability of the model.
- 1 June 2005
- Published by Wiley in Biotechnology and Applied Biochemistry
- Vol. 41 (3) , 255-264
A detailed understanding of the enhanced hypothermic productivity of interferon‐γ by Chinese‐hamster ovary cells
Culturing CHO (Chinese‐hamster ovary) cells at low temperature leads to growth arrest in the G0/G1 phase of the cell cycle and, in many cases, causes an increase in the specific productivity of recombinant protein. Controlled proliferation is often used to increase CHO specific productivity, and thus there is speculation that the enhanced productivity at low temperature is due to G0/G1‐phase growth arrest. However, we show that the positive effect of low temperature on recombinant protein production is due to elevated mRNA levels and not due to growth arrest and that a cell line can still exhibit growth‐associated productivity at low temperatures. Using a CHO cell producing recombinant human IFN‐γ (interferon‐γ), we show that productivity increases as the percentage of cells in the S phase of the cell cycle increases, at both 32 and 37°C. The increased productivity is due to higher recombinant IFN‐γ mRNA levels. We also show that, for a given cell‐cycle distribution, specific productivity increases as the temperature is lowered from 37 to 32°C. Thus specific productivity is maximized when cells are actively growing (high percentage of S‐phase cells) and also exposed to low temperature. These findings have important implications for cell‐culture optimization and cell‐line engineering, providing evidence that a CHO cell line capable of actively growing at low temperature would provide improved total protein production relative to the current growth strategies, namely 37°C active growth or low‐temperature growth arrest.
- 1 June 2005
- Published by Wiley in Biotechnology and Applied Biochemistry
- Vol. 41 (3) , 255-264
A detailed understanding of the enhanced hypothermic productivity of interferon‐γ by Chinese‐hamster ovary cells
Culturing CHO (Chinese‐hamster ovary) cells at low temperature leads to growth arrest in the G0/G1 phase of the cell cycle and, in many cases, causes an increase in the specific productivity of recombinant protein. Controlled proliferation is often used to increase CHO specific productivity, and thus there is speculation that the enhanced productivity at low temperature is due to G0/G1‐phase growth arrest. However, we show that the positive effect of low temperature on recombinant protein production is due to elevated mRNA levels and not due to growth arrest and that a cell line can still exhibit growth‐associated productivity at low temperatures. Using a CHO cell producing recombinant human IFN‐γ (interferon‐γ), we show that productivity increases as the percentage of cells in the S phase of the cell cycle increases, at both 32 and 37°C. The increased productivity is due to higher recombinant IFN‐γ mRNA levels. We also show that, for a given cell‐cycle distribution, specific productivity increases as the temperature is lowered from 37 to 32°C. Thus specific productivity is maximized when cells are actively growing (high percentage of S‐phase cells) and also exposed to low temperature. These findings have important implications for cell‐culture optimization and cell‐line engineering, providing evidence that a CHO cell line capable of actively growing at low temperature would provide improved total protein production relative to the current growth strategies, namely 37°C active growth or low‐temperature growth arrest.
- 1 June 2005
- Published by Wiley in Biotechnology and Applied Biochemistry
- Vol. 41 (3) , 265-272
Active hypothermic growth: a novel means for increasing total interferon‐γ production by Chinese‐hamster ovary cells
When grown under hypothermic conditions, CHO (Chinese‐hamster ovary) cells become growth‐arrested in the G0/G1 phase of the cell cycle and also often exhibit increased recombinant‐protein production. We have shown in the accompanying paper [Fox, Tan, Tan, Wong, Yap and Wang (2005) Biotechnol. Appl. Biochem. 41, 255–264] that the positive effect of low temperature on recombinant‐protein production is due to elevated mRNA levels and not due to G0/G1‐phase growth arrest and that a cell line can still show growth‐associated productivity at low temperature. This finding led to the hypothesis that improved total production of recombinant protein would be achieved by stimulating cells to actively grow at low temperature, a culture condition previously unreported in the literature. In the present study we have validated this hypothesis by stimulating hypothermic (32°C) growth through the use of different growth factors. Hypothermic growth was stimulated in fetal‐bovine‐serum‐supplemented adherent cultures using basic fibroblast growth factor or insulin. Hypothermic growth was also stimulated in suspension cultures normally grown in protein‐free medium by using supplementation with fetal bovine serum. These methods resulted in up to 7.7‐ and 4.9‐fold increases in total recombinant‐protein production compared with the 37 and 32°C control cultures respectively. This proof‐of‐concept study will motivate the creation of cell lines capable of growing at low temperatures for use in industrial processes.
- 1 June 2005
- Published by Wiley in Biotechnology and Applied Biochemistry
- Vol. 41 (3) , 265-272
Active hypothermic growth: a novel means for increasing total interferon‐γ production by Chinese‐hamster ovary cells
When grown under hypothermic conditions, CHO (Chinese‐hamster ovary) cells become growth‐arrested in the G0/G1 phase of the cell cycle and also often exhibit increased recombinant‐protein production. We have shown in the accompanying paper [Fox, Tan, Tan, Wong, Yap and Wang (2005) Biotechnol. Appl. Biochem. 41, 255–264] that the positive effect of low temperature on recombinant‐protein production is due to elevated mRNA levels and not due to G0/G1‐phase growth arrest and that a cell line can still show growth‐associated productivity at low temperature. This finding led to the hypothesis that improved total production of recombinant protein would be achieved by stimulating cells to actively grow at low temperature, a culture condition previously unreported in the literature. In the present study we have validated this hypothesis by stimulating hypothermic (32°C) growth through the use of different growth factors. Hypothermic growth was stimulated in fetal‐bovine‐serum‐supplemented adherent cultures using basic fibroblast growth factor or insulin. Hypothermic growth was also stimulated in suspension cultures normally grown in protein‐free medium by using supplementation with fetal bovine serum. These methods resulted in up to 7.7‐ and 4.9‐fold increases in total recombinant‐protein production compared with the 37 and 32°C control cultures respectively. This proof‐of‐concept study will motivate the creation of cell lines capable of growing at low temperatures for use in industrial processes.
- 10 December 2003
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 85 (2) , 177-184
Maximizing interferon‐γ production by chinese hamster ovary cells through temperature shift optimization: Experimental and modeling
The Chinese hamster ovary (CHO) cell line producing interferon‐γ (IFN‐γ) exhibits a 2‐fold increase in specific productivity when grown at 32°C compared to 37°C. Low temperature also causes growth arrest, meaning that the cell density is significantly lower at 32°C, nutrients are consumed at a slower rate and the batch culture can be run for a longer period of time prior to the onset of cell death. At the end of the batch, product concentration is doubled at the low temperature. However, the batch time is nearly doubled as well, and this causes volumetric productivity to only marginally improve by using low temperature. One approach to alleviate the problem of slow growth at low temperature is to utilize a biphasic process, wherein cells are cultured at 37°C for a period of time in order to obtain reasonably high cell density and then the temperature is shifted to 32°C to achieve high specific productivity. Using this approach, it is hypothesized that IFN‐γ volumetric productivity would be maximized. We developed and validated a model for predicting the optimal point in time at which to shift the culture temperature from 37°C to 32°C. It was found that by shifting the temperature after 3 days of growth, the IFN‐γ volumetric productivity is increased by 40% compared to growth and production at 32°C and by 90% compared to 37°C, without any decrease in total production relative to culturing at 32°C alone. The modeling framework presented here is applicable for optimizing controlled proliferation processes in general.
- 10 December 2003
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 85 (2) , 177-184
Maximizing interferon‐γ production by chinese hamster ovary cells through temperature shift optimization: Experimental and modeling
The Chinese hamster ovary (CHO) cell line producing interferon‐γ (IFN‐γ) exhibits a 2‐fold increase in specific productivity when grown at 32°C compared to 37°C. Low temperature also causes growth arrest, meaning that the cell density is significantly lower at 32°C, nutrients are consumed at a slower rate and the batch culture can be run for a longer period of time prior to the onset of cell death. At the end of the batch, product concentration is doubled at the low temperature. However, the batch time is nearly doubled as well, and this causes volumetric productivity to only marginally improve by using low temperature. One approach to alleviate the problem of slow growth at low temperature is to utilize a biphasic process, wherein cells are cultured at 37°C for a period of time in order to obtain reasonably high cell density and then the temperature is shifted to 32°C to achieve high specific productivity. Using this approach, it is hypothesized that IFN‐γ volumetric productivity would be maximized. We developed and validated a model for predicting the optimal point in time at which to shift the culture temperature from 37°C to 32°C. It was found that by shifting the temperature after 3 days of growth, the IFN‐γ volumetric productivity is increased by 40% compared to growth and production at 32°C and by 90% compared to 37°C, without any decrease in total production relative to culturing at 32°C alone. The modeling framework presented here is applicable for optimizing controlled proliferation processes in general.